Kun Wang

28PUBLICATIONS
67CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Radiation therapyPharmacogenomicsPredictive and prognostic markersCancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (28)

|Apr 28, 2026
Celecoxib Mitigates Paclitaxel-Induced Peripheral Neuropathy Through Modulation of the COX-2/PGE2 Pathway in Rats.

|Apr 13, 2026
The role of radiomics in predicting the response to neoadjuvant chemotherapy for breast cancer.

Yilin Chen, Ye Qin, Man Yang

|Mar 23, 2026
Timing of Pegfilgrastim Administration and Pegfilgrastim-Induced Bone Pain : A Prospective, Randomized, Phase 3 Trial.

Peiyong Li, Yitian Chen, Yingyi Lin

|Jan 23, 2026
Neoadjuvant Taxane Plus Trastuzumab and Pertuzumab With or Without Carboplatin in Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: The Randomized Noninferiority Phase III neoCARHP Trial.

Hong-Fei Gao, Guo-Lin Ye, Ying Lin

|Jul 31, 2025
Incorporating sentinel chain involvement pattern to predict non-sentinel lymph nodes status in breast cancer after neoadjuvant chemotherapy.

Minting Liang, Teng Zhu, Na Huang

|Jul 04, 2025
Multiomic integration reveals subtype-specific predictors of neoadjuvant treatment response in breast cancer.

Zongchao Mo, Mei Yang, Zhihan Zhu

Pageof 5

Frequent Collaborators

4 joint publications

Liulu Zhang

4 joint publications

Minyi Cheng

4 joint publications

Ciqiu Yang

3 joint publications

Xiaosheng Zhuang